These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12046391)

  • 21. [Glucocorticotherapy in hepatic diseases].
    Boroń P; Borzuchowska A; Modzelewski T
    Przegl Lek; 1970; 26(10):753-5. PubMed ID: 5484242
    [No Abstract]   [Full Text] [Related]  

  • 22. [Branched-chain amino acids for patients with liver disease--an effective treatment or scientific humbug?].
    Eriksson LS; Wahren J
    Lakartidningen; 1984 Feb; 81(9):774-6. PubMed ID: 6708678
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic action of pyrimidine derivatives in liver diseases (a review of the literature)].
    Rychnev VE; Frolov VM
    Vrach Delo; 1980 Apr; (4):58-61. PubMed ID: 6992450
    [No Abstract]   [Full Text] [Related]  

  • 24. [Significance of gastrointestinal antibiotics in gastrointestinal diseases: Normix, the non-absorbable antibiotic].
    Orv Hetil; 2006 Oct; 147(42):2055-6. PubMed ID: 17447340
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experiences with Vitamin B-12 therapy of chronic liver diseases in a resort practice].
    André W
    Munch Med Wochenschr; 1966 Mar; 108(11):610-1. PubMed ID: 6013869
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental study of Rheum officinale Baill. in treating severe hepatitis and hepatic coma].
    Hu LH
    Zhong Xi Yi Jie He Za Zhi; 1986 Jan; 6(1):41-2, 5. PubMed ID: 2942280
    [No Abstract]   [Full Text] [Related]  

  • 27. Abnormal enhancing lesion of dentate nuclei causing neurologic symptoms induced by metronidazole toxicity.
    Deenadayalu VP; Orinion EJ; Chalasani NP; Yoo HY
    Clin Gastroenterol Hepatol; 2005 Mar; 3(3):xxix. PubMed ID: 15765436
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent report of 4 cases of hepatic necrosis associated with trimethoprim-sulfonamide administration.
    Dodds WJ
    J Vet Intern Med; 1997; 11(4):267-8. PubMed ID: 9298485
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 30. Is hydrophobia necessary for the hepatologist prescribing nonselective beta-blockers in cirrhosis?
    Senzolo M; Nadal E; Cholongitas E; Burroughs AK
    Hepatology; 2011 Jun; 53(6):2149-50. PubMed ID: 21400554
    [No Abstract]   [Full Text] [Related]  

  • 31. Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study.
    Reuken PA; Pletz MW; Baier M; Pfister W; Stallmach A; Bruns T
    Aliment Pharmacol Ther; 2012 May; 35(10):1199-208. PubMed ID: 22449290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The liver: a pharmacologic perspective.
    Bossone CM
    Nurs Clin North Am; 1977 Jun; 12(2):291-303. PubMed ID: 585856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term therapy of liver diseases].
    Markoff N
    Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment guidelines for hepatic encephalopathy.
    Thompson JR
    Pharmacotherapy; 2010 May; 30(5 Pt 2):4S-9S. PubMed ID: 20412034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment options for hepatic encephalopathy.
    Schiano TD
    Pharmacotherapy; 2010 May; 30(5 Pt 2):16S-21S. PubMed ID: 20412036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of antibiotic treatment on the dynamics of oxidative stress in spontaneous bacterial peritonitis.
    Dănulescu RM; Ciobică A; Stanciu C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):598-604. PubMed ID: 24502022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of acute and chronic hepatic encephalopathy in cirrhosis].
    Doffoel M; Bockel R
    Ann Gastroenterol Hepatol (Paris); 1984; 20(3):163-6. PubMed ID: 6529174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.